Navigation Links
Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27
Date:4/9/2008

DETROIT, April 9 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute is accepting nominations for the Patricia Milner Sachs Heart of a Survivor Award. The award recognizes an outstanding cancer survivor who exemplifies caring, compassion and devotion to helping others in their journey to survive cancer. The award will be given at the Karmanos Cancer Institute's Survivorship Celebration on June 19. Nominations are open to all cancer survivors.

(Logo:

http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITUTELOG O )

This is the second year for the award, named in honor of Patricia Milner Sachs, a former Karmanos employee who lost her 11-year battle with melanoma in June 2006. Through her dedication to Karmanos and her commitment to cancer education and awareness, Sachs developed several community programs, including Survivorship University, free lectures for cancer survivors and their caregivers; "N'Siah" support group; and S.H.I.E.L.D., a sun safety and skin cancer awareness program for children and adults. Sachs exemplified service to other cancer survivors as she courageously battled the disease.

Nomination forms for the Patricia Milner Sachs Heart of a Survivor Award are available at http://www.karmanos.org. Nominations must be received at the Karmanos Cancer Institute by April 27, 2008.

Located in mid-town Detroit, MI, the Barbara Ann Karmanos Cancer Institute is one of 39 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff
'/>"/>

SOURCE Barbara Ann Karmanos Cancer Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cadient Group Receives Multiple Nominations for 2008 DTC National Advertising Awards
2. Cherokee Inspired Comfort Awards Program Call for Nominations
3. OSHA Seeking Nominations for National Advisory Committee on Occupational Safety and Health
4. Nanotech Briefs Announces Call for Nominations for the Fourth Annual Nano 50(TM) Awards
5. Shareholder Proposals and Director Nominations Due November 5, 2007
6. PA Governor Rendell Announces Latest Nominations and Appointments
7. Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology
8. Recognizing outstanding young researchers
9. Breaking Boundaries Program Honors Colorectal Cancer Survivors for Outstanding Leadership Achievements
10. Endu Receives Gold Medal for Outstanding Chinese Patented Invention Award
11. Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009).../PRNewswire-Asia/ -- Chindex International, Inc.,...ding independent American,provider of Western hea...blic,of China, today announced that the Company w... to be held in Shanghai on January 12th and 13th. ...l be held at the Pudong Shangri-,La hotel in Shan...
(Date:1/8/2009)...sing traditional risk factors, experts say , ...lecular signs -- or "biomarkers" -- of inflammatio...sess a person,s risk of stroke, new research says....ng these markers does not change things much," sai...t at the Methodist DeBakey Heart & Vascular Ce...
(Date:1/8/2009)... business continues to drive overall performance ,... Corporation (ZixCorp(R)), (Nasdaq: ZIXI ), the ... e-prescribing, today offered a corporate update b..."We ended the year on a high note in our Email Enc...for the year in the fourth quarter," said Spurr. ...
(Date:1/8/2009)...wswire-USNewswire/ -- A proposal by the State of I...hildren,s Home has prompted the 125,000-member Ame...nnual Mid-Winter conference January 10-12, 2009, i...arly unanimous opposition to the proposal. , , ...000 in direct and in-kind support to the home, is ...
Breaking Medicine News(10 mins):Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4
...study was conducted on 2000 female flight attendan...65 to 1995. The results revealed that they rate t...arassed. This is of major // concern to the other ...public. Sexual harassment included women given un...
...novel study conducted to analyze the fluctuations ...evealed that it may vary over different seasons wi...further supported by the fact that there is a corr...physical activity. Researchers at University of Ma...
...llowing reports of contamination of a type of Came...ts containing these items have been recalled from ...e Food Standards Agency has // issued a warning no...e. A form of E.coli known as 026 that secretes a ...
...e United Nations Office on Drugs and Crimes (UNODC...ober 8 South Asian earthquake in Pakistan and Afgh... their miseries. To avert this // possibility, th...ops in collaboration with the Pakistani Ministry o...
Other Medicine News:Health News:Seasonal Variation In Exercise And Eating Habits Identified 2
(Date:1/7/2009)...IS, Jan. 7 Eli Lilly and...eceived a complete response letter from,the U.S. ...long-acting,injection (LAI) for acute and mainten...is continuing to work with the agency on the new d...require any additional clinical trials for the con...
(Date:1/7/2009)..., Jan. 7 ImQuest Life Sciences ann...pplication to the Food and Drug Administration to ...midinedione HIV inhibitor IQP-0410. ImQuest antici...t quarter of 2009. IQP-0410 is a novel small molec...nucleoside reverse transcriptase inhibitor (NNRTI)...
(Date:1/7/2009)...gland, January 7 Circassia Ltd, a ...lergy and critical care, today,announced that fol...8 with,its ToleroMune(R) anti-allergy technology,...t for a further phase II clinical trial in cat all... recruited 120 patients with confirmed,cat allerg...
(Date:1/6/2009)... Jan. 6 In recent controlled studi...f Memphis , scientists found that the patented ing...st and only proven ingredient to increase levels o...g blood nitrate/nitrate (NOx) in human subjects. ,...es an increase in blood flow to the skeletal muscl...
Breaking Medicine Technology:FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2IBT Laboratories Expands its Menu of Tests for Immune Deficiency 3525 1IBT Laboratories Expands its Menu of Tests for Immune Deficiency 3525 2These shells dont clam up 3A Innovative technique to record human impact on coastal waters 6127 1EIN News Introduces Brain Cancer News Today 3B Website Offers Information on Risk Factors Treatment Drugs 31054 1EIN News Introduces Brain Cancer News Today 3B Website Offers Information on Risk Factors Treatment Drugs 31054 2Gene which protects against lung cancer identified 31049 1Gene which protects against lung cancer identified 31049 2
...ELS, Belgium and KOS, Greece, June 29, 2007 /PRNew... updated data for,previously treated patients on R...one shows median survival of 35 months, nearly,thr...mized,controlled Phase III trials that enrolled mo...s worldwide. These updated results,were presented ...
... Presentation of efficacy trends from ongoing phas... ESMO for presentation in,press conference , MARTI...ny,MediGene AG (Frankfurt, Prime Standard: MDG) an...al trial of MediGene,s cancer killing,virus will b...pean,Society for Medical Oncology. Out of more tha...
Other Medicine Technology:The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2European Society for Medical Oncology (ESMO) Presents Data from the,Clinical Trial of MediGene's Cancer-Killing Virus in Press,Conference 2
...-ms bursts of 50 Hz separated by .75 s. , Twitch: ... 100 Hz (100 pulses/s) , Train-Of-Four: Single (4...0 mA , Stimulus Pulse: Square Wave Monophasic pul...reen) indicates that the units on; it flashes when...
Anesthesia Associates Nerve Stimulator Model AA 1050
...ral nerve stimulator from B. Braun Medical. It is ...viding advanced digital technology. , ,Your abili...the localization of practically all mixed nerves f...tional optional component for the HNS11 is a steam...
Based on the original MS-III design the new MS-IV includes electrosurgery certification, enhanced keypad and battery compartment designs., ,The MiniStim® MS-IV peripheral nerve stimulator can
Medicine Products: